Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 9/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | SHBG | P04278 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19016270 | 0.98 | EPHX1 (0.33) | CYP1A2EPHX1ALDH1A1KDM4EHSD17B10 | |
| SCHEMBL25798184 | 0.92 | CYP1A2 (0.34) | CYP1A2EPHX1ALDH1A1KDM4EHSD17B10 | |
| SCHEMBL21166221 | 0.89 | CYP1A2 (0.42) | CYP1A2EPHX1SIGMAR1EPHX2 | |
| SCHEMBL19983332 | 0.83 | CYP1A2 (0.43) | CYP1A2EPHX1SIGMAR1EPHX2 | |
| SCHEMBL8451118 | 0.83 | EPHX1 (0.37) | CYP1A2EPHX1ALDH1A1KDM4EHSD17B10 | |
| SCHEMBL23084777 | 0.82 | ALDH1A1 (0.38) | CYP1A2EPHX1ALDH1A1KDM4EHSD17B10 | |
| SCHEMBL20033718 | 0.82 | CYP1A2 (0.42) | CYP1A2EPHX1SIGMAR1EPHX2 | |
| SCHEMBL19334479 | 0.80 | CYP1A2 (0.41) | CYP1A2EPHX1SIGMAR1EPHX2 | |
| SCHEMBL22001216 | 0.80 | EPHX1 (0.34) | CYP1A2EPHX1ALDH1A1KDM4EHSD17B10 | |
| SCHEMBL21166196 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230041563-A1 | N-(1,3,4-OXADIAZOL-2-YL)ARYLCARBOXAMIDES OR SALTS THEREOF, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND USES THEREOF | QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD. (CN) | 2023-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230041563-A1 | N-(1,3,4-OXADIAZOL-2-YL)ARYLCARBOXAMIDES OR SALTS THEREOF, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND USES THEREOF | CYP2B6, CBR3, CYP2A6 | CYP1A2 40/4885EPHX1 2131/4885ALDH1A1 2826/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.